Kaplan-Meier survival analyses of progression-free survival (PFS) in patients with prostate cancer. Kaplan-Meier analysis of the progression-free survival (PFS) in 137 patients with prostate cancer in relation to age (A), prostate-specific antigen (PSA) level (B), Gleason score (C), T stage (D), lymph node metastasis (E), seminal vesicle invasion (SVI) (F), surgical margin (G), and TRIM11 expression level (H).